Skip to main content
SpringerLink
Log in

Portal Hypertension and Liver Transplantation: Current Situation in Japan and Overseas

  • Chapter
  • First Online:
Book cover Clinical Investigation of Portal Hypertension

  • 1000 Accesses

Abstract

Liver transplantation is the only curative treatment option for both portal hypertension and end-stage liver disease (ESLD). In Japan, 50–60 deceased-donor liver transplant (DDLTs) and 400–500 living-donor liver transplant (LDLTs) are performed per year. Spain is the most DDLT-active country, and South Korea is the most LDLT-active country, performing 52 times as many and 5 times as many liver transplants per capita than Japan, respectively. Managing portal hypertension, ascites, hepatorenal syndrome, and spontaneous bacterial peritonitis is the key for bridging the interim period in patients waiting for liver transplantation. The Baveno VI consensus workshop recommendation is an important strategy for portal hypertension patients. International ascites club guidelines are other crucial strategies for ESLD patients. For a successful liver transplantation, multidisciplinary approach is essential to manage patients during both pre- and posttransplant periods. Regarding post-liver transplant patients, although liver transplantation resolves portal hypertension, a small-for-size graft in LDLT, acute rejection, and recurrence of the original liver disease may lead to newly developing or recurring portal hypertension. Further studies are needed to develop a management strategy for portal hypertension in pre- and post-liver transplant patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet. 1963;117:659–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Organ Procurement and Transplantation Network data. http://optn.transplant.hrsa.gov. Accessed 18 July 2016.

  3. Trotter JF, Cardenas A. Liver transplantation around the world. Liver Transpl. 2016;22(8):1059–61.

    Article  Google Scholar 

  4. Eurotransplant. https://www.eurotransplant.org/cms/. Accessed 18 July 2016.

  5. Wang H, Jiang W, Zhou Z, Long J, Li W, Fan ST. Liver transplantation in mainland China: the overview of CLTR 2011 annual scientific report. Hepatobiliary Surg Nutr. 2013;2(4):188–97.

    PubMed  PubMed Central  Google Scholar 

  6. Trey T, Halpern A, Singh MA. Organ transplantation and regulation in China. JAMA. 2011;306(17):1863–4; author reply 4.

    Article  CAS  Google Scholar 

  7. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med. 1990;322(21):1505–7.

    Article  CAS  Google Scholar 

  8. Raia S, Nery JR, Mies S. Liver transplantation from live donors. Lancet. 1989;2(8661):497.

    Article  CAS  Google Scholar 

  9. Nagasue N, Kohno H, Matsuo S, Yamanoi A, Uchida M, Takemoto Y, et al. Segmental (partial) liver transplantation from a living donor. Transplant Proc. 1992;24(5):1958–9.

    CAS  PubMed  Google Scholar 

  10. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, et al. Successful living-related partial liver transplantation to an adult patient. Lancet. 1994;343(8907):1233–4.

    Article  CAS  Google Scholar 

  11. Japan OrganTransplant Network. https://www.jotnw.or.jp/english/index.html. Accessed 18 July 2016.

  12. Chen CL, Kabiling CS, Concejero AM. Why does living donor liver transplantation flourish in Asia? Nat Rev Gastroenterol Hepatol. 2013;10(12):746–51.

    Article  Google Scholar 

  13. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71.

    Article  CAS  Google Scholar 

  14. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797–805.

    Article  Google Scholar 

  15. MELD and PELD Calculator by Organ Procurement and Transplantation Network. https://optn.transplant.hrsa.gov/resources/allocation-calculators/about-meld-and-peld/. Accessed 18 July 2016.

  16. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant. 2005;5(2):307–13.

    Article  Google Scholar 

  17. Zaman A, Hapke R, Flora K, Rosen H, Benner K. Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol. 1999;94(4):895–9.

    Article  CAS  Google Scholar 

  18. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.

    Article  CAS  Google Scholar 

  19. Wedd J, Bambha KM, Stotts M, Laskey H, Colmenero J, Gralla J, et al. Stage of cirrhosis predicts the risk of liver-related death in patients with low model for end-stage liver disease scores and cirrhosis awaiting liver transplantation. Liver Transpl. 2014;20(10):1193–201.

    Article  Google Scholar 

  20. Cardenas A, Gines P. Management of patients with cirrhosis awaiting liver transplantation. Gut. 2011;60(3):412–21.

    Article  Google Scholar 

  21. de Franchis R. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52.

    Article  Google Scholar 

  22. Centre for Evidence-Based Medicine. http://www.cebm.net/. Accessed 10 Oct 2016.

  23. Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015;64(4):531–7.

    Article  CAS  Google Scholar 

  24. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41(6):1282–9.

    Article  Google Scholar 

  26. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397–417.

    Article  Google Scholar 

  27. Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130(6):1652–60.

    Article  Google Scholar 

  28. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med. 2006;355(20):2099–112.

    Article  CAS  Google Scholar 

  29. Samsca (tolvaptan): drug warning—potential risk of liver injury by U.S. Food and Drug Administration. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm336669.htm. Accessed 10 Oct 2016.

  30. Cheng YF, Ou HY, Tsang LL, Yu CY, Huang TL, Chen TY, et al. Vascular stents in the management of portal venous complications in living donor liver transplantation. Am J Transplant. 2010;10(5):1276–83.

    Article  Google Scholar 

  31. Arab JP, Meneses L, Perez RM, Arrese M, Benitez C. Hepatic encephalopathy in a liver transplant recipient with stable liver function. Hepatology. 2013;57(4):1672–4.

    Article  Google Scholar 

  32. Herrero JI, Bilbao JI, Diaz ML, Alegre F, Inarrairaegui M, Pardo F, et al. Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: treatment with embolization of portosystemic collaterals. Liver Transpl. 2009;15(1):111–4.

    Article  Google Scholar 

  33. Abe S, Akamatsu N, Hoshikawa M, Shirata C, Sakamoto Y, Hasegawa K, et al. Ectopic jejunal variceal rupture in a liver transplant recipient successfully treated with percutaneous transhepatic coil embolization: a case report. Medicine. 2015;94(47):e2151.

    Article  Google Scholar 

  34. Starzl TE. The long reach of liver transplantation. Nat Med. 2012;18(10):1489–92.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hepato-Billiary-Pancreatic Surgery Division, Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Junichi Kaneko

  2. National Center for Global Health and Medicine, Tokyo, Japan

    Norihiro Kokudo

Authors
  1. Junichi Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norihiro Kokudo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norihiro Kokudo .

Editor information

Editors and Affiliations

  1. Department of Advanced Gastrointestinal Endoscopy, Fukushima Medical University, Fukushima, Japan

    Katsutoshi Obara

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kaneko, J., Kokudo, N. (2019). Portal Hypertension and Liver Transplantation: Current Situation in Japan and Overseas. In: Obara, K. (eds) Clinical Investigation of Portal Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-10-7425-7_60

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7425-7_60

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7424-0

  • Online ISBN: 978-981-10-7425-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation